ELISPOT assays and their diagnostic potential in Lyme disease and Lyme neuroborreliosis
- PMID: 32180218
- PMCID: PMC8202138
- DOI: 10.1111/cei.13431
ELISPOT assays and their diagnostic potential in Lyme disease and Lyme neuroborreliosis
Keywords: ELISPOT; Lyme borreliosis; T cell assay; interferon-gamma; neuroborreliosis.
Conflict of interest statement
N. E. S. acts as a paid employee at GenID GmbH and as paid consultant to AID GmbH. R. P. acts as a paid employee at GenID GmbH and as a paid consultant to AID GmbH.
Comment on
-
Prospective comparison of two enzyme-linked immunosorbent spot assays for the diagnosis of Lyme neuroborreliosis.Clin Exp Immunol. 2020 Mar;199(3):337-356. doi: 10.1111/cei.13393. Epub 2020 Jan 7. Clin Exp Immunol. 2020. PMID: 31665540 Free PMC article.
References
-
- Mygland A, Ljøstad U, Fingerle V et al. EFNS guidelines on the diagnosis and management of European Lyme neuroborreliosis. Eur J Neurol 2010; 17:8–16, e1–4. - PubMed
-
- Hammers‐Berggren S, Hansen K, Lebech AM, Karlsson M. Borrelia burgdorferi‐specific intrathecal antibody production in neuroborreliosis: a follow‐up study. Neurology 1993; 43:169–75. - PubMed
-
- Blanc F, Jaulhac B, Fleury M et al. Relevance of the antibody index to diagnose Lyme neuroborreliosis among seropositive patients. Neurology 2007; 69:953–8. - PubMed